{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T03:40:05Z","timestamp":1755920405975,"version":"3.44.0"},"reference-count":59,"publisher":"Pharmaceutical Society of Japan","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2025,8,19]]},"DOI":"10.1248\/bpb.b25-00258","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T22:06:20Z","timestamp":1755554780000},"page":"1213-1223","source":"Crossref","is-referenced-by-count":0,"title":["Effects of Low-Dose Atorvastatin on Hypoxic Response in Statin-Sensitive and Statin-Resistant Cancer Cells"],"prefix":"10.1248","volume":"48","author":[{"given":"Akihiro","family":"Sugiura","sequence":"first","affiliation":[{"name":"Division of Basic Veterinary Science, Joint Graduate School of Veterinary Sciences, Tottori University, 4\u2013101 Koyama-cho, Minami, Tottori 680\u20138553, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Warita","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, School of Biological and Environmental Sciences, Kwansei Gakuin University, 1 Gakuen Uegahara, Sanda, Hyogo 669\u20131330, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiro","family":"Tashiro","sequence":"additional","affiliation":[{"name":"Division of Basic Veterinary Science, Joint Graduate School of Veterinary Sciences, Tottori University, 4\u2013101 Koyama-cho, Minami, Tottori 680\u20138553, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuro","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Division of Basic Veterinary Science, Joint Graduate School of Veterinary Sciences, Tottori University, 4\u2013101 Koyama-cho, Minami, Tottori 680\u20138553, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhiko","family":"Warita","sequence":"additional","affiliation":[{"name":"Division of Basic Veterinary Science, Joint Graduate School of Veterinary Sciences, Tottori University, 4\u2013101 Koyama-cho, Minami, Tottori 680\u20138553, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Perlikos F, Harrington KJ, Syrigos KN. Key molecular mechanisms in lung cancer invasion and metastasis: a comprehensive review. <i>Crit. Rev. Oncol. Hematol.<\/i>, <b>87<\/b>, 1\u201311 (2013).","DOI":"10.1016\/j.critrevonc.2012.12.007"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Mehlen P, Puisieux A. Metastasis: a question of life or death. <i>Nat. Rev. Cancer<\/i>, <b>6<\/b>, 449\u2013458 (2006).","DOI":"10.1038\/nrc1886"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Sleeman J, Steeg PS. Cancer metastasis as a therapeutic target. <i>Eur. J. Cancer<\/i>, <b>46<\/b>, 1177\u20131180 (2010).","DOI":"10.1016\/j.ejca.2010.02.039"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Rankin EB, Giaccia AJ. Hypoxic control of metastasis. <i>Science<\/i>, <b>352<\/b>, 175\u2013180 (2016).","DOI":"10.1126\/science.aaf4405"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. <i>Cell<\/i>, <b>147<\/b>, 275\u2013292 (2011).","DOI":"10.1016\/j.cell.2011.09.024"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Suhail Y, Cain MP, Vanaja K, Kurywchak PA, Levchenko A, Kalluri R, Kshitiz. Systems biology of cancer metastasis. <i>Cell Syst.<\/i>, <b>9<\/b>, 109\u2013127 (2019).","DOI":"10.1016\/j.cels.2019.07.003"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Sounni NE, Noel A. Targeting the tumor microenvironment for cancer therapy. <i>Clin. Chem.<\/i>, <b>59<\/b>, 85\u201393 (2013).","DOI":"10.1373\/clinchem.2012.185363"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Hajizadeh F, Okoye I, Esmaily M, Ghasemi Chaleshtari M, Masjedi A, Azizi G, Irandoust M, Ghalamfarsa G, Jadidi-Niaragh F. Hypoxia inducible factors in the tumor microenvironment as therapeutic targets of cancer stem cells. <i>Life Sci.<\/i>, <b>237<\/b>, 116952 (2019).","DOI":"10.1016\/j.lfs.2019.116952"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Wu T, Dai Y. Tumor microenvironment and therapeutic response. <i>Cancer Lett.<\/i>, <b>387<\/b>, 61\u201368 (2017).","DOI":"10.1016\/j.canlet.2016.01.043"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. <i>Nat. Med.<\/i>, <b>19<\/b>, 1423\u20131437 (2013).","DOI":"10.1038\/nm.3394"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Shay JE, Celeste Simon M. Hypoxia-inducible factors: crosstalk between inflammation and metabolism. <i>Semin. Cell Dev. Biol.<\/i>, <b>23<\/b>, 389\u2013394 (2012).","DOI":"10.1016\/j.semcdb.2012.04.004"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Majmundar AJ, Wong WJ, Simon MC. Hypoxia-inducible factors and the response to hypoxic stress. <i>Mol. Cell<\/i>, <b>40<\/b>, 294\u2013309 (2010).","DOI":"10.1016\/j.molcel.2010.09.022"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Semenza GL. Targeting HIF-1 for cancer therapy. <i>Nat. Rev. Cancer<\/i>, <b>3<\/b>, 721\u2013732 (2003).","DOI":"10.1038\/nrc1187"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Albadari N, Deng S, Li W. The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy. <i>Expert Opin. Drug Discov.<\/i>, <b>14<\/b>, 667\u2013682 (2019).","DOI":"10.1080\/17460441.2019.1613370"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Licarete E, Sesarman A, Rauca VF, Luput L, Patras L, Banciu M. HIF-1\u03b1 acts as a molecular target for simvastatin cytotoxicity in B16.F10 melanoma cells cultured under chemically induced hypoxia. <i>Oncol. Lett.<\/i>, <b>13<\/b>, 3942\u20133950 (2017).","DOI":"10.3892\/ol.2017.5928"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Lu T, Tang J, Shrestha B, Heath BR, Hong L, Lei YL, Ljungman M, Neamati N. Up-regulation of hypoxia-inducible factor antisense as a novel approach to treat ovarian cancer. <i>Theranostics<\/i>, <b>10<\/b>, 6959\u20136976 (2020).","DOI":"10.7150\/thno.41792"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Sirtori CR. The pharmacology of statins. <i>Pharmacol. Res.<\/i>, <b>88<\/b>, 3\u201311 (2014).","DOI":"10.1016\/j.phrs.2014.03.002"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Nielsen SF, Nordestgaard BG, Bojesen SE. Statin use and reduced cancer-related mortality. <i>N. Engl. J. Med.<\/i>, <b>367<\/b>, 1792\u20131802 (2012).","DOI":"10.1056\/NEJMoa1201735"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Manthravadi S, Shrestha A, Madhusudhana S. Impact of statin use on cancer recurrence and mortality in breast cancer: a systematic review and meta-analysis. <i>Int. J. Cancer<\/i>, <b>139<\/b>, 1281\u20131288 (2016).","DOI":"10.1002\/ijc.30185"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Mei Z, Liang M, Li L, Zhang Y, Wang Q, Yang W. Effects of statins on cancer mortality and progression: a systematic review and meta-analysis of 95 cohorts including 1,111,407 individuals. <i>Int. J. Cancer<\/i>, <b>140<\/b>, 1068\u20131081 (2017).","DOI":"10.1002\/ijc.30526"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Osmak M. Statins and cancer: current and future prospects. <i>Cancer Lett.<\/i>, <b>324<\/b>, 1\u201312 (2012).","DOI":"10.1016\/j.canlet.2012.04.011"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Islam M, Sharma S, Kumar B, Teknos TN. Atorvastatin inhibits RhoC function and limits head and neck cancer metastasis. <i>Oral Oncol.<\/i>, <b>49<\/b>, 778\u2013786 (2013).","DOI":"10.1016\/j.oraloncology.2013.04.003"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Zheng C, Yan S, Lu L, Yao H, He G, Chen S, Li Y, Peng X, Cheng Z, Wu M, Zhang Q, Li G, Fu S, Deng X. Lovastatin inhibits EMT and metastasis of triple-negative breast cancer stem cells through dysregulation of cytoskeleton-associated proteins. <i>Front. Oncol.<\/i>, <b>11<\/b>, 656687 (2021).","DOI":"10.3389\/fonc.2021.656687"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Chen B, Zhang M, Xing D, Feng Y. Atorvastatin enhances radiosensitivity in hypoxia-induced prostate cancer cells related with HIF-1\u03b1 inhibition. <i>Biosci. Rep.<\/i>, <b>37<\/b>, BSR20170340 (2017).","DOI":"10.1042\/BSR20170340"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Liu J, Wang H, Zhang M, Li Y, Wang R, Chen H, Wang B, Gao X, Song S, Wang Y, Ren Y, Li J, Liu P. Metformin and simvastatin synergistically suppress endothelin 1-induced hypoxia and angiogenesis in multiple cancer types. <i>Cancer Sci.<\/i>, <b>114<\/b>, 640\u2013653 (2023).","DOI":"10.1111\/cas.15602"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Wang JC, Li XX, Sun X, Li GY, Sun JL, Ye YP, Cong LL, Li WM, Lu SY, Feng J, Liu PJ. Activation of AMPK by simvastatin inhibited breast tumor angiogenesis <i>via<\/i> impeding HIF-1\u03b1-induced pro-angiogenic factor. <i>Cancer Sci.<\/i>, <b>109<\/b>, 1627\u20131637 (2018).","DOI":"10.1111\/cas.13570"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Mylonis I, Simos G, Paraskeva E. Hypoxia-inducible factors and the regulation of lipid metabolism. <i>Cells<\/i>, <b>8<\/b>, 214 (2019).","DOI":"10.3390\/cells8030214"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Mucaj V, Shay JES, Simon MC. Effects of hypoxia and HIFs on cancer metabolism. <i>Int. J. Hematol.<\/i>, <b>95<\/b>, 464\u2013470 (2012).","DOI":"10.1007\/s12185-012-1070-5"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Dulak J, J\u00f3zkowicz A. Anti-angiogenic and anti-inflammatory effects of statins: relevance to anti-cancer therapy. <i>Curr. Cancer Drug Targets<\/i>, <b>5<\/b>, 579\u2013594 (2005).","DOI":"10.2174\/156800905774932824"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Tomaszewski M, St\u0119pie\u0144 KM, Tomaszewska J, Czuczwar SJ. Statin-induced myopathies. <i>Pharmacol. Rep.<\/i>, <b>63<\/b>, 859\u2013866 (2011).","DOI":"10.1016\/S1734-1140(11)70601-6"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Warita K, Warita T, Beckwitt CH, Schurdak ME, Vazquez A, Wells A, Oltvai ZN. Statin-induced mevalonate pathway inhibition attenuates the growth of mesenchymal-like cancer cells that lack functional E-cadherin mediated cell cohesion. <i>Sci. Rep.<\/i>, <b>4<\/b>, 7593 (2014).","DOI":"10.1038\/srep07593"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Ishikawa T, Hosaka YZ, Beckwitt C, Wells A, Oltvai ZN, Warita K. Concomitant attenuation of HMG-CoA reductase expression potentiates the cancer cell growth-inhibitory effect of statins and expands their efficacy in tumor cells with epithelial characteristics. <i>Oncotarget<\/i>, <b>9<\/b>, 29304\u201329315 (2018).","DOI":"10.18632\/oncotarget.25448"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Grada A, Otero-Vinas M, Prieto-Castrillo F, Obagi Z, Falanga V. Research techniques made simple: analysis of collective cell migration using the wound healing assay. <i>J. Invest. Dermatol.<\/i>, <b>137<\/b>, e11\u2013e16 (2017).","DOI":"10.1016\/j.jid.2016.11.020"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Liu Z, Wang Y, Dou C, Xu M, Sun L, Wang L, Yao B, Li Q, Yang W, Tu K, Liu Q. Hypoxia-induced up-regulation of VASP promotes invasiveness and metastasis of hepatocellular carcinoma. <i>Theranostics<\/i>, <b>8<\/b>, 4649\u20134663 (2018).","DOI":"10.7150\/thno.26789"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Li J, Guo Y, Duan L, Hu X, Zhang X, Hu J, Huang L, He R, Hu Z, Luo W, Tan T, Huang R, Liao D, Zhu YS, Luo DX. AKR1B10 promotes breast cancer cell migration and invasion <i>via<\/i> activation of ERK signaling. <i>Oncotarget<\/i>, <b>8<\/b>, 33694\u201333703 (2017).","DOI":"10.18632\/oncotarget.16624"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Banciu M, Schiffelers RM, Fens MH, Metselaar JM, Storm G. Anti-angiogenic effects of liposomal prednisolone phosphate on B16 melanoma in mice. <i>J. Control. Release<\/i>, <b>113<\/b>, 1\u20138 (2006).","DOI":"10.1016\/j.jconrel.2006.03.019"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Rauca VF, Licarete E, Luput L, Sesarman A, Patras L, Bulzu P, Rakosy-Tican E, Banciu M. Combination therapy of simvastatin and 5, 6-dimethylxanthenone-4-acetic acid synergistically suppresses the aggressiveness of B16.F10 melanoma cells. <i>PLOS ONE<\/i>, <b>13<\/b>, e0202827 (2018).","DOI":"10.1371\/journal.pone.0202827"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Jing X, Yang F, Shao C, Wei K, Xie M, Shen H, Shu Y. Role of hypoxia in cancer therapy by regulating the tumor microenvironment. <i>Mol. Cancer<\/i>, <b>18<\/b>, 157 (2019).","DOI":"10.1186\/s12943-019-1089-9"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Sowa T, Menju T, Chen-Yoshikawa TF, Takahashi K, Nishikawa S, Nakanishi T, Shikuma K, Motoyama H, Hijiya K, Aoyama A, Sato T, Sonobe M, Harada H, Date H. Hypoxia-inducible factor 1 promotes chemoresistance of lung cancer by inducing carbonic anhydrase IX expression. <i>Cancer Med.<\/i>, <b>6<\/b>, 288\u2013297 (2017).","DOI":"10.1002\/cam4.991"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Koshiji M, Kageyama Y, Pete EA, Horikawa I, Barrett JC, Huang LE. HIF-1\u03b1 induces cell cycle arrest by functionally counteracting Myc. <i>EMBO J.<\/i>, <b>23<\/b>, 1949\u20131956 (2004).","DOI":"10.1038\/sj.emboj.7600196"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Hubbi ME, Semenza GL. Regulation of cell proliferation by hypoxia-inducible factors. <i>Am. J. Physiol. Cell Physiol.<\/i>, <b>309<\/b>, C775\u2013C782 (2015).","DOI":"10.1152\/ajpcell.00279.2015"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Zimna A, Kurpisz M. Hypoxia-inducible factor-1 in physiological and pathophysiological angiogenesis: applications and therapies. <i>BioMed Res. Int.<\/i>,  <b>2015<\/b>, 549412 (2015).","DOI":"10.1155\/2015\/549412"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Mansoori B, Mohammadi A, Davudian S, Shirjang S, Baradaran B. The different mechanisms of cancer drug resistance: a brief review. <i>Adv. Pharm. Bull.<\/i>, <b>7<\/b>, 339\u2013348 (2017).","DOI":"10.15171\/apb.2017.041"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Chen R, Manochakian R, James L, Azzouqa AG, Shi H, Zhang Y, Zhao Y, Zhou K, Lou Y. Emerging therapeutic agents for advanced non-small cell lung cancer. <i>J. Hematol. Oncol.<\/i>, <b>13<\/b>, 58 (2020).","DOI":"10.1186\/s13045-020-00881-7"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Tandberg DJ, Tong BC, Ackerson BG, Kelsey CR. Surgery <i>versus<\/i> stereotactic body radiation therapy for stage I non-small cell lung cancer: a comprehensive review. <i>Cancer<\/i>, <b>124<\/b>, 667\u2013678 (2018).","DOI":"10.1002\/cncr.31196"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Nagasaka M, Gadgeel SM. Role of chemotherapy and targeted therapy in early-stage non-small cell lung cancer. <i>Expert Rev. Anticancer Ther.<\/i>, <b>18<\/b>, 63\u201370 (2018).","DOI":"10.1080\/14737140.2018.1409624"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Wood SL, Pernemalm M, Crosbie PA, Whetton AD. The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets. <i>Cancer Treat. Rev.<\/i>, <b>40<\/b>, 558\u2013566 (2014).","DOI":"10.1016\/j.ctrv.2013.10.001"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Marcian\u00f2 G, Palleria C, Casarella A, Rania V, Basile E, Catarisano L, Vocca C, Bianco L, Pelaia C, Cione E, D\u2019Agostino B, Citraro R, De Sarro G, Gallelli L. Effect of statins on lung cancer molecular pathways: a possible therapeutic role. <i>Pharmaceuticals<\/i> (Basel), <b>15<\/b>, 589 (2022).","DOI":"10.3390\/ph15050589"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Tian H, Qiang T, Wang J, Ji L, Li B. Simvastatin regulates the proliferation, apoptosis, migration and invasion of human acute myeloid leukemia cells <i>via<\/i> miR-19a-3p\/HIF-1\u03b1 axis. <i>Bioengineered<\/i>, <b>12<\/b>, 11898\u201311908 (2021).","DOI":"10.1080\/21655979.2021.1999552"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Fiorentino FP, Tokg\u00fcn E, Sol\u00e9-S\u00e1nchez S, Giampaolo S, Tokg\u00fcn O, Jauset T, Kohno T, Perucho M, Soucek L, Yokota J. Growth suppression by MYC inhibition in small cell lung cancer cells with TP53 and RB1 inactivation. <i>Oncotarget<\/i>, <b>7<\/b>, 31014\u201331028 (2016).","DOI":"10.18632\/oncotarget.8826"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Gordan JD, Thompson CB, Simon MC. HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation. <i>Cancer Cell<\/i>, <b>12<\/b>, 108\u2013113 (2007).","DOI":"10.1016\/j.ccr.2007.07.006"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. <i>Cell<\/i>, <b>147<\/b>, 275\u2013292 (2011).","DOI":"10.1016\/j.cell.2011.09.024"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Fidler IJ, Kripke ML. The challenge of targeting metastasis. <i>Cancer Metastasis Rev.<\/i>, <b>34<\/b>, 635\u2013641 (2015).","DOI":"10.1007\/s10555-015-9586-9"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Han XJ, Yang ZJ, Jiang LP, Wei YF, Liao MF, Qian Y, Li Y, Huang X, Wang JB, Xin HB, Wan YY. Mitochondrial dynamics regulates hypoxia-induced migration and antineoplastic activity of cisplatin in breast cancer cells. <i>Int. J. Oncol.<\/i>, <b>46<\/b>, 691\u2013700 (2015).","DOI":"10.3892\/ijo.2014.2781"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Gupta MK, Qin R. Mechanism and its regulation of tumor-induced angiogenesis. <i>World J. Gastroenterol.<\/i>, <b>9<\/b>, 1144\u20131155 (2003).","DOI":"10.3748\/wjg.v9.i6.1144"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. <i>Cell<\/i>, <b>86<\/b>, 353\u2013364 (1996).","DOI":"10.1016\/S0092-8674(00)80108-7"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. <i>J. Clin. Oncol.<\/i>, <b>23<\/b>, 1011\u20131027 (2005).","DOI":"10.1200\/JCO.2005.06.081"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) Lee SJ, Lee I, Lee J, Park C, Kang WK. Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, potentiate the anti-angiogenic effects of bevacizumab by suppressing angiopoietin2, BiP, and Hsp90\u03b1 in human colorectal cancer. <i>Br. J. Cancer<\/i>, <b>111<\/b>, 497\u2013505 (2014).","DOI":"10.1038\/bjc.2014.283"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59) Tsai CL, Changchien CY, Chen Y, Lai CR, Chen TM, Chang HH, Tsai WC, Tsai YL, Tsai HC, Lin HY, Wang CY, Shen MS, Lin YH. Survival benefit of statin with anti-angiogenesis efficacy in lung cancer-associated pleural fluid through FXR modulation. <i>Cancers<\/i> (Basel), <b>14<\/b>, 2765 (2022).","DOI":"10.3390\/cancers14112765"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/8\/48_b25-00258\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T03:24:41Z","timestamp":1755919481000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/8\/48_b25-00258\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":59,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b25-00258","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"type":"print","value":"0918-6158"},{"type":"electronic","value":"1347-5215"}],"subject":[],"published":{"date-parts":[[2025,8,19]]},"article-number":"b25-00258"}}